Status:
RECRUITING
Genetic Markers of Diabetic Ulcers and Personalized Treatment Targets Research
Lead Sponsor:
The First Affiliated Hospital of University of South China
Conditions:
Diabetic Ulcers
Eligibility:
All Genders
18+ years
Brief Summary
This clinical trial involves collecting peripheral blood, ulcer tissue, and fecal samples from diabetic ulcer patients for bioinformatics analysis to screen genetic markers significantly associated wi...
Eligibility Criteria
Inclusion
- 1\) Subjects who voluntarily participate in this clinical study and sign informed consent;
- 2\) Patients with type 2 diabetes and diabetic ulcers;
- 3\) Disease duration ≥ 10 years or age ≥ 55 years at enrollment;
- 4\) Inpatient or outpatient who can be monitored by the same investigating team throughout the duration of the study.
Exclusion
- 1\) Severe vascular occlusion or impairment;
- 2\) Patients with congenital heart disease, aortic dissection, or other severe cardiovascular diseases;
- 3\) Patients with ulcers caused by factors other than diabetes;
- 4\) Patients with severe liver and kidney dysfunction or serious neurological impairment.
Key Trial Info
Start Date :
May 16 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
May 16 2027
Estimated Enrollment :
712 Patients enrolled
Trial Details
Trial ID
NCT06979037
Start Date
May 16 2024
End Date
May 16 2027
Last Update
May 18 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The First Affiliated Hospital of University of South China
Hengyang, Hunan, China, 421001